Your browser doesn't support javascript.
loading
Algorithms for the identification of prevalent diabetes in the All of Us Research Program validated using polygenic scores - a new resource for diabetes precision medicine.
Szczerbinski, Lukasz; Mandla, Ravi; Schroeder, Philip; Porneala, Bianca C; Li, Josephine H; Florez, Jose C; Mercader, Josep M; Manning, Alisa K; Udler, Miriam S.
Affiliation
  • Szczerbinski L; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
  • Mandla R; Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
  • Schroeder P; Programs in Metabolism and Medical & Population Genetics, Broad Institute of Harvard and MIT, Cambridge, USA.
  • Porneala BC; Center for Genomic Medicine, Massachusetts General Hospital, Boston, USA.
  • Li JH; Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Florez JC; Programs in Metabolism and Medical & Population Genetics, Broad Institute of Harvard and MIT, Cambridge, USA.
  • Mercader JM; Center for Genomic Medicine, Massachusetts General Hospital, Boston, USA.
  • Manning AK; Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Udler MS; Cardiology Division, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, USA.
medRxiv ; 2023 Sep 05.
Article in En | MEDLINE | ID: mdl-37732265
OBJECTIVE: The study aimed to develop and validate algorithms for identifying people with type 1 and type 2 diabetes in the All of Us Research Program (AoU) cohort, using electronic health record (EHR) and survey data. RESEARCH DESIGN AND METHODS: Two sets of algorithms were developed, one using only EHR data (EHR), and the other using a combination of EHR and survey data (EHR+). Their performance was evaluated by testing their association with polygenic scores for both type 1 and type 2 diabetes. RESULTS: For type 1 diabetes, the EHR-only algorithm showed a stronger association with T1D polygenic score (p=3×10-5) than the EHR+. For type 2 diabetes, the EHR+ algorithm outperformed both the EHR-only and the existing AoU definition, identifying additional cases (25.79% and 22.57% more, respectively) and showing stronger association with T2D polygenic score (DeLong p=0.03 and 1×10-4, respectively). CONCLUSIONS: We provide new validated definitions of type 1 and type 2 diabetes in AoU, and make them available for researchers. These algorithms, by ensuring consistent diabetes definitions, pave the way for high-quality diabetes research and future clinical discoveries.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: MedRxiv Year: 2023 Document type: Article Affiliation country: Poland Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: MedRxiv Year: 2023 Document type: Article Affiliation country: Poland Country of publication: United States